UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The relationship of age with the clinical phenotype in multiple sclerosis

Multiple sclerosis, 2016-11, Vol.22 (13), p.1750-1758

2016

Volltextzugriff (PDF)

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis

Trials, 2019-05, Vol.20 (1), p.263-263, Article 263

2019

Volltextzugriff (PDF)

SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking

Bone marrow transplantation (Basingstoke), 2015-02, Vol.50 (2), p.173-180

2015

Volltextzugriff (PDF)

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations

Bone marrow transplantation (Basingstoke), 2021-07, Vol.56 (7), p.1493-1508

2021

Volltextzugriff (PDF)

Rare side effects of alemtuzumab remind us of the need for postmarketing surveillance

Neurology, 2018-05, Vol.90 (18), p.819-820

2018

Volltextzugriff (PDF)

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients

The Journal of experimental medicine, 2005-03, Vol.201 (5), p.805-816

2005

Volltextzugriff (PDF)

A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper

Multiple sclerosis, 2012-06, Vol.18 (6), p.825-834

2012

Volltextzugriff (PDF)

Renewing the T cell repertoire to arrest autoimmune aggression

Trends in Immunology, 2006-02, Vol.27 (2), p.61-67

2006

Volltextzugriff (PDF)

Development of oral immunomodulatory agents in the management of multiple sclerosis

Drug design, development and therapy, 2011, Vol.5, p.255-274

2011

Volltextzugriff (PDF)

Redundancy in Antigen-Presenting Function of the HLA-DR and -DQ Molecules in the Multiple Sclerosis-Associated HLA-DR2 Haplotype

Journal of Immunology, 2006-02, Vol.176 (3), p.1951-1961

2006

Volltextzugriff (PDF)

Molecular tracking of antigen‐specific T cell clones in neurological immune‐mediated disorders

Brain (London, England : 1878), 2003-01, Vol.126 (1), p.20-31

2003

Volltextzugriff (PDF)

Clonotypic analysis of cerebrospinal fluid T cells during disease exacerbation and remission in a patient with multiple sclerosis

Journal of neuroimmunology, 2006-02, Vol.171 (1), p.177-183

2006

Volltextzugriff (PDF)

Decreased integrin gene expression in patients with MS responding to interferon-β treatment

Journal of neuroimmunology, 2004-05, Vol.150 (1), p.123-131

2004

Volltextzugriff (PDF)

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a multi-center, randomized, double blind, cross-over phase 2 clinical trial with autologous mesenchymal stem cells (MSC)

MULTIPLE SCLEROSIS JOURNAL, 2019, Vol.25, p.759

2019

Volltextzugriff (PDF)

Human Autoreactive CD4+ T Cells from Naive CD45RA+ and Memory CD45RO+ Subsets Differ with Respect to Epitope Specificity and Functional Antigen Avidity

The Journal of immunology (1950), 2000-05, Vol.164 (10), p.5474-5481

2000

Volltextzugriff (PDF)

VLA-4/CD49d downregulated on primed T lymphocytes during interferon-β therapy in multiple sclerosis

Journal of neuroimmunology, 2000-11, Vol.111 (1), p.186-194

2000

Volltextzugriff (PDF)

Unique clinical and pathological features in HLA-DRB10401-restricted MBP 111-129-specific humanized TCR transgenic mice

The Journal of experimental medicine, 2004-07, Vol.200 (2), p.223-234

2004

Volltextzugriff (PDF)

T cell response to 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in multiple sclerosis patients

Journal of neuroimmunology, 2002-09, Vol.130 (1), p.233-242

2002

Volltextzugriff (PDF)

Hematopoietic stem cell transplantation for multiple sclerosis: current status and future challenges

Current opinion in neurology, 2003-06, Vol.16 (3), p.299-305

2003

Volltextzugriff (PDF)

An international solution to recruiting physician-scientists?

Nature medicine, 2002-09, Vol.8 (9), p.902-903

Muraro, Paolo A

2002

Volltextzugriff (PDF)

Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7

Journal of neuroimmunology, 1999-12, Vol.100 (1), p.115-123

1999

Volltextzugriff (PDF)

Immunological questions on hematopoietic stem cell transplantation for multiple sclerosis

Bone marrow transplantation (Basingstoke), 2003-08, Vol.32 (S1), p.S41-S44

2003

Volltextzugriff (PDF)

Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B10401) subjects is associated with a restricted T cell receptor repertoire

The Journal of clinical investigation, 1997-07, Vol.100 (2), p.339-349

1997

Volltextzugriff (PDF)

Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vβ analysis

Journal of immunological methods, 2000-12, Vol.246 (1), p.131-143

2000

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(43)
Tagungsberichte
(1)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The relationship of age with the clinical phenotype in multiple sclerosis

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis

SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations

Rare side effects of alemtuzumab remind us of the need for postmarketing surveillance

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients

A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper

Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee

Renewing the T cell repertoire to arrest autoimmune aggression

Development of oral immunomodulatory agents in the management of multiple sclerosis

Redundancy in Antigen-Presenting Function of the HLA-DR and -DQ Molecules in the Multiple Sclerosis-Associated HLA-DR2 Haplotype

Molecular tracking of antigen‐specific T cell clones in neurological immune‐mediated disorders

Clonotypic analysis of cerebrospinal fluid T cells during disease exacerbation and remission in a patient with multiple sclerosis

Decreased integrin gene expression in patients with MS responding to interferon-β treatment

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a multi-center, randomized, double blind, cross-over phase 2 clinical trial with autologous mesenchymal stem cells (MSC)

Human Autoreactive CD4+ T Cells from Naive CD45RA+ and Memory CD45RO+ Subsets Differ with Respect to Epitope Specificity and Functional Antigen Avidity

VLA-4/CD49d downregulated on primed T lymphocytes during interferon-β therapy in multiple sclerosis

Unique clinical and pathological features in HLA-DRB10401-restricted MBP 111-129-specific humanized TCR transgenic mice

T cell response to 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in multiple sclerosis patients

Hematopoietic stem cell transplantation for multiple sclerosis: current status and future challenges

An international solution to recruiting physician-scientists?

Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7

Immunological questions on hematopoietic stem cell transplantation for multiple sclerosis

Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B10401) subjects is associated with a restricted T cell receptor repertoire

Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vβ analysis

Suchergebnisse filtern